Skip to main content
Erschienen in: Journal of Clinical Immunology 1/2017

17.10.2016 | Original Article

Targeted Sequencing and Immunological Analysis Reveal the Involvement of Primary Immunodeficiency Genes in Pediatric IBD: a Japanese Multicenter Study

verfasst von: Tasuku Suzuki, Yoji Sasahara, Atsuo Kikuchi, Humihiko Kakuta, Toshihiko Kashiwabara, Takashi Ishige, Yoshiko Nakayama, Masanori Tanaka, Akihiro Hoshino, Hirokazu Kanegane, Daiki Abukawa, Shigeo Kure

Erschienen in: Journal of Clinical Immunology | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Pediatric inflammatory bowel disease (IBD) is a heterogeneous disorder caused by multiple factors. Although genetic and immunological analyses are required for a definitive diagnosis, no reports of a comprehensive genetic study of a Japanese population are available.

Methods

In total, 35 Japanese patients <16 years of age suffering from IBD, including 27 patients aged <6 years with very early-onset IBD, were enrolled in this multicenter study. Exome and targeted gene panel sequencing was performed for all patients. Mutations in genes responsible for primary immunodeficiency diseases (PID) and clinical and immunological parameters were evaluated according to disease type.

Results

We identified monogenic mutations in 5 of the 35 patients (14.3 %). We identified compound heterozygous and homozygous splice-site mutations in interleukin-10 receptor A (IL-10RA) in two patients, nonsense mutations in X-linked inhibitor of apoptosis protein (XIAP) in two patients, and a missense mutation in cytochrome b beta chain in one patient. Using assays for protein expression levels, IL-10 signaling, and cytokine production, we confirmed that the mutations resulted in loss of function. For each patient, genotype was significantly associated with clinical findings. We successfully treated a patient with a XIAP mutation by allogeneic cord blood hematopoietic stem cell transplantation, and his symptoms were ameliorated completely.

Conclusions

Targeted sequencing and immunological analysis are useful for screening monogenic disorders and selecting curative therapies in pediatric patients with IBD. The genes responsible for PID are frequently involved in pediatric IBD and play critical roles in normal immune homeostasis in the gastrointestinal tract.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Benchimol EI, Mack DR, Nguyen GC, Snapper SB, Li W, Mojaverian N, et al. Incidence, outcome, and health services burden of very early onset inflammatory bowel disease. Gastroenterology. 2014;147:803–13.CrossRefPubMed Benchimol EI, Mack DR, Nguyen GC, Snapper SB, Li W, Mojaverian N, et al. Incidence, outcome, and health services burden of very early onset inflammatory bowel disease. Gastroenterology. 2014;147:803–13.CrossRefPubMed
3.
Zurück zum Zitat Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119–24.CrossRefPubMedPubMedCentral Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119–24.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Glocker EO, Kotlarz D, Boztug K, Gertz EM, Schäffer AA, Noyan F, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med. 2009;361:2033–45.CrossRefPubMedPubMedCentral Glocker EO, Kotlarz D, Boztug K, Gertz EM, Schäffer AA, Noyan F, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med. 2009;361:2033–45.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Glocker EO, Frede N, Perro M, Sebire N, Elawad M, Shah N, et al. Infant colitis--it’s in the genes. Lancet. 2010;376:1272.CrossRefPubMed Glocker EO, Frede N, Perro M, Sebire N, Elawad M, Shah N, et al. Infant colitis--it’s in the genes. Lancet. 2010;376:1272.CrossRefPubMed
6.
Zurück zum Zitat Blaydon DC, Biancheri P, Di WL, Plaqnol V, Cabral RM, Brooke MA, et al. Inflammatory skin and bowel disease linked to ADAM17 deletion. N Engl J Med. 2011;365:1502–8.CrossRefPubMed Blaydon DC, Biancheri P, Di WL, Plaqnol V, Cabral RM, Brooke MA, et al. Inflammatory skin and bowel disease linked to ADAM17 deletion. N Engl J Med. 2011;365:1502–8.CrossRefPubMed
7.
Zurück zum Zitat Uhlig HH. Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease. Gut. 2013;62:1795–805.CrossRefPubMed Uhlig HH. Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease. Gut. 2013;62:1795–805.CrossRefPubMed
8.
Zurück zum Zitat Cutler DJ, Zwick ME, Okou DT, Prahalad S, Walters T, Guthery SL, et al. Dissecting allele architecture of early onset IBD using high-density genotyping. PLoS ONE. 2015;10:e0128074.CrossRefPubMedPubMedCentral Cutler DJ, Zwick ME, Okou DT, Prahalad S, Walters T, Guthery SL, et al. Dissecting allele architecture of early onset IBD using high-density genotyping. PLoS ONE. 2015;10:e0128074.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Kammermeier J, Drury S, James CT, Dziubak R, Ocaka L, Elawad M, et al. Targeted gene panel sequencing in children with very early onset inflammatory bowel disease-evaluation and prospective analysis. J Med Genet. 2014;51:748–55.CrossRefPubMed Kammermeier J, Drury S, James CT, Dziubak R, Ocaka L, Elawad M, et al. Targeted gene panel sequencing in children with very early onset inflammatory bowel disease-evaluation and prospective analysis. J Med Genet. 2014;51:748–55.CrossRefPubMed
10.
Zurück zum Zitat Uhlig HH, Schwerd T, Koletzko S, Shah N, Kammermeier J, Elkadri A, et al. The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology. 2014;147:990–1007.CrossRefPubMed Uhlig HH, Schwerd T, Koletzko S, Shah N, Kammermeier J, Elkadri A, et al. The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology. 2014;147:990–1007.CrossRefPubMed
11.
Zurück zum Zitat Christodoulou K, Wiskin AE, Gibson J, Tapper W, Willis C, Afzal NA, et al. Next generation exome sequencing of pediatric inflammatory bowel disease patients identifies rare and novel variants in candidate genes. Gut. 2013;62:977–84.CrossRefPubMed Christodoulou K, Wiskin AE, Gibson J, Tapper W, Willis C, Afzal NA, et al. Next generation exome sequencing of pediatric inflammatory bowel disease patients identifies rare and novel variants in candidate genes. Gut. 2013;62:977–84.CrossRefPubMed
12.
Zurück zum Zitat Ishige T, Tomomasa T, Takebayashi T, Asakura K, Watanabe M, Suzuki T, et al. Inflammatory bowel disease in children: epidemiological analysis of the nationwide IBD registry in Japan. J Gastroenterol. 2010;45:911–7.CrossRefPubMed Ishige T, Tomomasa T, Takebayashi T, Asakura K, Watanabe M, Suzuki T, et al. Inflammatory bowel disease in children: epidemiological analysis of the nationwide IBD registry in Japan. J Gastroenterol. 2010;45:911–7.CrossRefPubMed
13.
Zurück zum Zitat Maisawa S, Sasaki M, Ida S, Uchida K, Kagimoto S, Shimizu T, et al. Characteristics of inflammatory bowel disease with an onset before eight years of age: a multicenter epidemiological survey in Japan. J Gastroenterol Hepatol. 2013;28:499–504.CrossRefPubMed Maisawa S, Sasaki M, Ida S, Uchida K, Kagimoto S, Shimizu T, et al. Characteristics of inflammatory bowel disease with an onset before eight years of age: a multicenter epidemiological survey in Japan. J Gastroenterol Hepatol. 2013;28:499–504.CrossRefPubMed
14.
Zurück zum Zitat Asakura K, Nishiwaki Y, Inoue N, Hibi T, Watanabe M, Takebayashi T. Prevalence of ulcerative colitis and Crohn’s disease in Japan. J Gastroenterol. 2009;44:659–65.CrossRefPubMed Asakura K, Nishiwaki Y, Inoue N, Hibi T, Watanabe M, Takebayashi T. Prevalence of ulcerative colitis and Crohn’s disease in Japan. J Gastroenterol. 2009;44:659–65.CrossRefPubMed
15.
Zurück zum Zitat Kuwahara E, Asakura K, Nishiwaki Y, Inoue N, Watanabe M, Hibi T, et al. Effects of family history on inflammatory bowel disease characteristics in Japanese patients. J Gastroenterol. 2012;47:961–8.CrossRefPubMed Kuwahara E, Asakura K, Nishiwaki Y, Inoue N, Watanabe M, Hibi T, et al. Effects of family history on inflammatory bowel disease characteristics in Japanese patients. J Gastroenterol. 2012;47:961–8.CrossRefPubMed
16.
Zurück zum Zitat Russell RK, Satsangi J. IBD: a family affair. Best Pract Res Clin Gastroenterol. 2004;18:525–39.CrossRefPubMed Russell RK, Satsangi J. IBD: a family affair. Best Pract Res Clin Gastroenterol. 2004;18:525–39.CrossRefPubMed
17.
Zurück zum Zitat Inoue N, Tamura K, Kinouchi Y, Fukuda Y, Takahashi S, Ogura Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn’s disease. Gastroenterology. 2002;123:86–91.CrossRefPubMed Inoue N, Tamura K, Kinouchi Y, Fukuda Y, Takahashi S, Ogura Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn’s disease. Gastroenterology. 2002;123:86–91.CrossRefPubMed
18.
Zurück zum Zitat Yamazaki K, Umeno J, Takahashi A, Hirano A, Johnson TA, Kumasaka N, et al. A genome-wide association study identifies 2 susceptibility loci for Crohn’s disease in a Japanese population. Gastroenterology. 2013;144:781–8.CrossRefPubMed Yamazaki K, Umeno J, Takahashi A, Hirano A, Johnson TA, Kumasaka N, et al. A genome-wide association study identifies 2 susceptibility loci for Crohn’s disease in a Japanese population. Gastroenterology. 2013;144:781–8.CrossRefPubMed
19.
Zurück zum Zitat Tsai MF, Lin YJ, Cheng YC, Lee KH, Huang CC, Chen YT, et al. Primer Z: streamlined primer design for promoters, exons and human SNPs. Nucleic Acids Res. 2007;35:W63–5.CrossRefPubMedPubMedCentral Tsai MF, Lin YJ, Cheng YC, Lee KH, Huang CC, Chen YT, et al. Primer Z: streamlined primer design for promoters, exons and human SNPs. Nucleic Acids Res. 2007;35:W63–5.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Wada T, Kanegane H, Ohta K, Katoh F, Imamura T, Nakazawa Y, et al. Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency. Cytokine. 2014;65:74–8.CrossRefPubMed Wada T, Kanegane H, Ohta K, Katoh F, Imamura T, Nakazawa Y, et al. Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency. Cytokine. 2014;65:74–8.CrossRefPubMed
21.
Zurück zum Zitat Donnelly RP, Dickensheets H, Finbloom DS. The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J Interferon Cytokine Res. 1999;19:563–73.CrossRefPubMed Donnelly RP, Dickensheets H, Finbloom DS. The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J Interferon Cytokine Res. 1999;19:563–73.CrossRefPubMed
22.
Zurück zum Zitat Begue B, Verdier J, Rieux-Laucat F, Goulet O, Morali A, Canioni D, et al. Defective IL-10 signaling defining a subgroup of patients with inflammatory bowel disease. Am J Gastroenterol. 2011;106:1544–55.CrossRefPubMed Begue B, Verdier J, Rieux-Laucat F, Goulet O, Morali A, Canioni D, et al. Defective IL-10 signaling defining a subgroup of patients with inflammatory bowel disease. Am J Gastroenterol. 2011;106:1544–55.CrossRefPubMed
23.
Zurück zum Zitat Shim JO, Hwang S, Yang HR, Moon JS, Chang JY, Ko JS, et al. Interleukin-10 receptor mutations in children with neonatal-onset Crohn’s disease and intractable ulcerating enterocolitis. Eur J Gastroenterol Hepatol. 2013;25:1235–40.PubMed Shim JO, Hwang S, Yang HR, Moon JS, Chang JY, Ko JS, et al. Interleukin-10 receptor mutations in children with neonatal-onset Crohn’s disease and intractable ulcerating enterocolitis. Eur J Gastroenterol Hepatol. 2013;25:1235–40.PubMed
24.
Zurück zum Zitat Kotlarz D, Beier R, Murugan D, Diestelhorst J, Jensen O, Boztug K, et al. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. Gastroenterology. 2012;143:347–55.CrossRefPubMed Kotlarz D, Beier R, Murugan D, Diestelhorst J, Jensen O, Boztug K, et al. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. Gastroenterology. 2012;143:347–55.CrossRefPubMed
25.
Zurück zum Zitat Pigneur B, Escher J, Elawad M, Lima R, Buderus S, Kierkus J, et al. Phenotypic characterization of very early-onset IBD due to mutations in the IL-10, IL-10 receptor alpha or beta gene: a survey of the genius working group. Inflamm Bowel Dis. 2013;19:2820–8.CrossRefPubMed Pigneur B, Escher J, Elawad M, Lima R, Buderus S, Kierkus J, et al. Phenotypic characterization of very early-onset IBD due to mutations in the IL-10, IL-10 receptor alpha or beta gene: a survey of the genius working group. Inflamm Bowel Dis. 2013;19:2820–8.CrossRefPubMed
26.
Zurück zum Zitat Neven B, Mamessier E, Bruneau J, Kaltenbach S, Kotlarz D, Suarez F, et al. A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency. Blood. 2013;122:3713–22.CrossRefPubMed Neven B, Mamessier E, Bruneau J, Kaltenbach S, Kotlarz D, Suarez F, et al. A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency. Blood. 2013;122:3713–22.CrossRefPubMed
27.
Zurück zum Zitat Lu D, Xu Y, Chen Y, Zeng P, Chen H, Zeng H. Interleukin-10 receptor mutations in children with neonatal onset inflammatory bowel disease: genetic diagnosis and pathogenesis. Chin J Pediatr. 2015;53:348–54. Lu D, Xu Y, Chen Y, Zeng P, Chen H, Zeng H. Interleukin-10 receptor mutations in children with neonatal onset inflammatory bowel disease: genetic diagnosis and pathogenesis. Chin J Pediatr. 2015;53:348–54.
28.
Zurück zum Zitat Krieg A, Correa RG, Garrison JB, Le Negrate G, Welsh K, Huang Z, et al. XIAP mediates NOD signaling via interaction with RIP2. Proc Natl Acad Sci U S A. 2009;106:14524–9.CrossRefPubMedPubMedCentral Krieg A, Correa RG, Garrison JB, Le Negrate G, Welsh K, Huang Z, et al. XIAP mediates NOD signaling via interaction with RIP2. Proc Natl Acad Sci U S A. 2009;106:14524–9.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Latour S, Aguilar C. XIAP deficiency syndrome in humans. Semin Cell Dev Biol. 2015;39:115–23.CrossRefPubMed Latour S, Aguilar C. XIAP deficiency syndrome in humans. Semin Cell Dev Biol. 2015;39:115–23.CrossRefPubMed
30.
Zurück zum Zitat Worthey EA, Mayer AN, Syverson GD, Helbling D, Bonacci BB, Decker B, et al. Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet Med. 2011;13:255–62.CrossRefPubMed Worthey EA, Mayer AN, Syverson GD, Helbling D, Bonacci BB, Decker B, et al. Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet Med. 2011;13:255–62.CrossRefPubMed
31.
Zurück zum Zitat Aguilar C, Lenoir C, Lambert N, Bèque B, Brousse N, Canioni D, et al. Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriers. J Allergy Clin Immunol. 2014;134:1131–41.CrossRefPubMed Aguilar C, Lenoir C, Lambert N, Bèque B, Brousse N, Canioni D, et al. Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriers. J Allergy Clin Immunol. 2014;134:1131–41.CrossRefPubMed
32.
Zurück zum Zitat Zeissig Y, Petersen BS, Milutinovic S, Bosse E, Mayr G, Peuker K, et al. XIAP variants in male Crohn’s disease. Gut. 2015;64:66–76.CrossRefPubMed Zeissig Y, Petersen BS, Milutinovic S, Bosse E, Mayr G, Peuker K, et al. XIAP variants in male Crohn’s disease. Gut. 2015;64:66–76.CrossRefPubMed
33.
Zurück zum Zitat Yang X, Kanegane H, Nishida N, Imamura T, Hamamoto K, Miyashita R, et al. Clinical and genetic characteristics of XIAP deficiency in Japan. J Clin Immunol. 2012;32:411–20.CrossRefPubMed Yang X, Kanegane H, Nishida N, Imamura T, Hamamoto K, Miyashita R, et al. Clinical and genetic characteristics of XIAP deficiency in Japan. J Clin Immunol. 2012;32:411–20.CrossRefPubMed
34.
Zurück zum Zitat Speckmann C, Lehmberg K, Albert MH, Damgaard RB, Fretsch M, Gyrd-Hansen M, et al. X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis. Clin Immunol. 2013;149:133–41.CrossRefPubMed Speckmann C, Lehmberg K, Albert MH, Damgaard RB, Fretsch M, Gyrd-Hansen M, et al. X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis. Clin Immunol. 2013;149:133–41.CrossRefPubMed
35.
Zurück zum Zitat Speckmann C, Ehl S. XIAP deficiency is a Mendelian cause of late-onset IBD. Gut. 2014;63:1031–2.CrossRefPubMed Speckmann C, Ehl S. XIAP deficiency is a Mendelian cause of late-onset IBD. Gut. 2014;63:1031–2.CrossRefPubMed
36.
Zurück zum Zitat Royer-Pokora B, Kunkel LM, Monaco AP, Goff SC, Newburger PE, Baehner RL, et al. Cloning the gene for an inherited human disorder-chronic granulomatous disease-on the basis of its chromosomal location. Nature. 1986;322:32–8.CrossRefPubMed Royer-Pokora B, Kunkel LM, Monaco AP, Goff SC, Newburger PE, Baehner RL, et al. Cloning the gene for an inherited human disorder-chronic granulomatous disease-on the basis of its chromosomal location. Nature. 1986;322:32–8.CrossRefPubMed
37.
38.
Zurück zum Zitat Dhillon SS, Fattouh R, Elkadri A, Xu W, Murchie R, Walters T, et al. Variants in nicotinamide adenine dinucleotide phosphate oxidase complex components determine susceptibility to very early onset inflammatory bowel disease. Gastroenterology. 2014;147:680–9.CrossRefPubMed Dhillon SS, Fattouh R, Elkadri A, Xu W, Murchie R, Walters T, et al. Variants in nicotinamide adenine dinucleotide phosphate oxidase complex components determine susceptibility to very early onset inflammatory bowel disease. Gastroenterology. 2014;147:680–9.CrossRefPubMed
39.
Zurück zum Zitat Schappi MG, Klein NJ, Lindley KJ, Rampling D, Smith VV, Goldblatt D, et al. The nature of colitis in chronic granulomatous disease. J Pediatr Gastroenterol Nutr. 2003;36:623–31.CrossRefPubMed Schappi MG, Klein NJ, Lindley KJ, Rampling D, Smith VV, Goldblatt D, et al. The nature of colitis in chronic granulomatous disease. J Pediatr Gastroenterol Nutr. 2003;36:623–31.CrossRefPubMed
40.
Zurück zum Zitat Kelsen JR, Dawany N, Moran CJ, Petersen BS, Sarmady M, Sasson A, et al. Exome sequencing analysis reveals variants in primary immunodeficiency genes in patients with very early onset inflammatory bowel disease. Gastroenterology. 2015;149:1415–24.CrossRefPubMedPubMedCentral Kelsen JR, Dawany N, Moran CJ, Petersen BS, Sarmady M, Sasson A, et al. Exome sequencing analysis reveals variants in primary immunodeficiency genes in patients with very early onset inflammatory bowel disease. Gastroenterology. 2015;149:1415–24.CrossRefPubMedPubMedCentral
Metadaten
Titel
Targeted Sequencing and Immunological Analysis Reveal the Involvement of Primary Immunodeficiency Genes in Pediatric IBD: a Japanese Multicenter Study
verfasst von
Tasuku Suzuki
Yoji Sasahara
Atsuo Kikuchi
Humihiko Kakuta
Toshihiko Kashiwabara
Takashi Ishige
Yoshiko Nakayama
Masanori Tanaka
Akihiro Hoshino
Hirokazu Kanegane
Daiki Abukawa
Shigeo Kure
Publikationsdatum
17.10.2016
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 1/2017
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-016-0339-5

Weitere Artikel der Ausgabe 1/2017

Journal of Clinical Immunology 1/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.